UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006572
Receipt number R000007747
Scientific Title Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthma
Date of disclosure of the study information 2011/10/18
Last modified on 2015/10/19 15:18:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthma

Acronym

Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthma

Scientific Title

Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthma

Scientific Title:Acronym

Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthma

Region

Japan


Condition

Condition

Patients with bronchial asthma aged 20 years and older (males and females, outpatients and inpatients) being treated with an ICS (at a dose equivalent to FP 200-1000 mcg/day) and salmeterol 100 mcg/day in combination (either as two separate products or one combined product) for 3 months or longer with poor or inadequate control

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the improved effects of budesonide/formoterol on airway inflammation and respiratory resistance in patients with bronchial asthma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of various indicators
1)Fraction of exhaled Nitric Oxide
2)Mostgraph
3)Airway resistance of interrupter method

Key secondary outcomes

Respiratory Function(FEV1)
Improvement of ACQ(asthma control questionnaire)score
Frequency of use of short-acting inhaled be-ta2 agonist(SABA)
Number of adverse event


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

budesonide/formoterol 160/4.5 mcg,2-4inhalations,twice a day

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Aged>=20years old
2)Patients who has diagnosed as bronchial asthma
3)Patients who has provided written consent prior to enrollment

Key exclusion criteria

1)Patients with infections with no available effective antimicrobial drugs or with deep mycosis.
2)Patients with a history of hypersensitivity(including contact dermatitis)to any ingredient contained in budesonide/formoterol.
3)Patients with tuberculous disease
4)5)Case with the following complications
-Severe liver disease
-Severe renal disease
6)Planning-to-be-pregnant,pregnant or lactating patients
7)Patients who are inappropriate considered by physician.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yosuke Tanaka

Organization

Chiba-Hokusoh Hospital, Nippon Medical School

Division name

Department of Respiratory Medicine

Zip code


Address

1715 Kamagari, Inzai, Chiba, 270-1694, Japan

TEL

0476991961

Email

yosuke-t@nms.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yosuke Tanaka

Organization

Chiba-Hokusoh Hospital, Nippon Medical School

Division name

Department of Respiratory Medicine

Zip code


Address

1715 Kamagari, Inzai, Chiba, 270-1694, Japan

TEL

0476991961

Homepage URL


Email

yosuke-t@nms.ac.jp


Sponsor or person

Institute

Chiba-Hokusoh Hospital, Nippon Medical School

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本医科大学千葉北総病院呼吸器センター(千葉県)


Other administrative information

Date of disclosure of the study information

2011 Year 10 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 10 Month 18 Day

Date of IRB


Anticipated trial start date

2011 Year 10 Month 01 Day

Last follow-up date

2013 Year 10 Month 01 Day

Date of closure to data entry

2015 Year 03 Month 31 Day

Date trial data considered complete

2015 Year 03 Month 31 Day

Date analysis concluded

2015 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2011 Year 10 Month 18 Day

Last modified on

2015 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007747


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name